Proxy Advisers Slam Allergan, Support Shareholder Meeting
Proxy advisory firms Institutional Shareholder Services and Glass Lewis have both come out criticizing Allergan Inc.'s efforts to block a special shareholder meeting to look at proposals relating to Valeant Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article